A main actor in Pharmaceutical Synthesis and Specialty Ingredients

Two main business activities supported by R&D expertise and global assets

A leader in pharmaceutical synthesis

Offering a wide range of technologies, Seqens provide its clients custom manufacturing services as well as a large portfolio of APIs & intermediates. We offer our customers with an access to our network of 3 R&D centers, 4 pilot units and 12 cGMP manufacturing sites and 6 cGMP multi-purposes sites to ensure a smooth in-house scale-up from early clinical phases to the commercial stage.


Cross-functional knowledge in specialty ingredients

Seqens offers a wide continuum of technologies covering small-scale to large-scale chemical synthesis and distillation including distinctive reactions such as Fiedel-Craft, Grignard and low-metal capabilities. This industrial network is supported by focused R&D capabilities. Seqens offers high purity oxygenated solvents leveraging its back-integrationl and a large range of Minerals Specialties produced.


A large expertise
in cosmetics

Seqens has built a wide, comprehensive and cutting edge offer for the cosmetic market sourced in pharmaceutics and fine chemistry know-hows.


A continuum of technologies

Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia.

More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.



Products & Technologies

[Interview] Seqens and Bordeaux INP launch a new Labcom : SPRINT

In January 2020, Seqens and the Bordeaux Institute of Technology (Bordeaux INP) launch a new Labcom under the name of SPRINT for…

Seqens group, member of the Global Compact

As part of its SD-CSR policy, Seqens is a member of the Global Compact. But what is the Global Compact? And what…

NOVAWOOD Winner of the CRE 5-3 call for tenders for the construction of a biomass cogeneration plant

NOVAWOOD PROJECT The French Energy Ministry announced the list of the biomass projects selected at the CRE 5 3rd period tender launched by…

Seqens global presence

Use interactive map



Scientists, experts and engineers


Manufacturing sites


Customers in more than 80 countries